EVELUT: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
R. Buhl (Mainz, Germany), M. Dreher (Aachen, Germany), M. Mattiucci-Guehlke (Ingelheim, Germany), S. Eckhardt (Gießen, Germany), C. Taube (Essen, Germany), C. Vogelmeier (Marburg, Germany), R. Buhl (Mainz, Germany)
Source: International Congress 2022 – COPD clinical studies and exacerbations
Session: COPD clinical studies and exacerbations
Session type: Thematic Poster
Number: 3623
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Buhl (Mainz, Germany), M. Dreher (Aachen, Germany), M. Mattiucci-Guehlke (Ingelheim, Germany), S. Eckhardt (Gießen, Germany), C. Taube (Essen, Germany), C. Vogelmeier (Marburg, Germany), R. Buhl (Mainz, Germany). EVELUT: dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS. 3623
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|